[When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention]

MMW Fortschr Med. 2000 Jul 27;142(30):33-4.
[Article in German]
No abstract available

MeSH terms

  • Anticholesteremic Agents / economics*
  • Anticholesteremic Agents / therapeutic use
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / economics*
  • Cost-Benefit Analysis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Recurrence

Substances

  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors